J.L. Bodmer

Discipline

Histoire, Philosophie et Sociologie des sciences (2)

Type de document

Articles (14) Recensions (1)

Co-auteur

Date

Source

Mot-clé

nécrose (13) Necrosis (13) Human beings (13) Necrosis (13) famille (11) Families (11) Receptors (11) Family (11) Amino acid sequence (10) protéine (9) membrane (9) Tumor necrosis factor (9) Animals (9) Apoptosis (8) Proteins (8) Mice (8) Cells (8) acide aminé (7) Death (7) Ligands (7) Death (7) mort (7) ligne (6) Transduction (5) Antigens (5) spectacle (4) Addition (4) tissu (corporel) (3) solubilité (3) mutation (3)

Documents écrit par J.L. Bodmer (14) | parle de J.L. Bodmer (0)

Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.
C. Bossen et al. (2006)
The molecular architecture of the TNF superfamily.
J.L. Bodmer et al. (2002)
Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL.
J.L. Bodmer et al. (2000)
Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.
N. Holler et al. (2000)
The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
F. Mühlenbeck et al. (2000)
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.
P. Schneider et al. (1999)
MyD88, an adapter protein involved in interleukin-1 signaling.
K. Burns et al. (1998)
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
P. Schneider et al. (1998)
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.
M. Hahne et al. (1998)
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.
P. Schneider et al. (1997)
Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.
P. Schneider et al. (1997)
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.
M. Thome et al. (1997)
Inhibition of death receptor signals by cellular FLIP.
M. Irmler et al. (1997)
Characterization of two receptors for TRAIL.
P. Schneider et al. (1997)